PWMG
TMDX icon

Prestige Wealth Management Group’s Transmedics TMDX Stock Holding History

Prestige Wealth Management Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39K Buy
24
+2
+9% +$261 ﹤0.01% 706
2025
Q4 		$2.68K Hold
22
– – ﹤0.01% 701
2025
Q3 		$2.47K Hold
22
– – ﹤0.01% 702
2025
Q2 		$2.95K Sell
22
-1
-4% -$110 ﹤0.01% 665
2025
Q1 		$1.55K Buy
23
+17
+283% +$1.17K ﹤0.01% 791
2024
Q4 		$375 Buy
+6
New +$559 ﹤0.01% 999

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prestige Wealth Management Group's TMDX Position: Q1 2026 in Review

Prestige Wealth Management Group increased its Transmedics (TMDX) stake by 9.1% in Q1 2026, buying an estimated $261 and bringing the position to 24 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Prestige Wealth Management Group first reported a position in TMDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.95K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Prestige Wealth Management Group held 24 shares of Transmedics worth $2.39K as of Q1 2026.
  • Prestige Wealth Management Group bought 2 Transmedics shares in Q1 2026, an estimated $261.
  • Transmedics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q1 2026, its #706 holding.
  • Prestige Wealth Management Group first reported a position in Transmedics in Q4 2024 and has held it in 6 quarters since.
  • Prestige Wealth Management Group's Transmedics position peaked at $2.95K in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.